Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 244

1.

Update: Demographic, Product, and Substance-Use Characteristics of Hospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injuries - United States, December 2019.

Lozier MJ, Wallace B, Anderson K, Ellington S, Jones CM, Rose D, Baldwin G, King BA, Briss P, Mikosz CA; Lung Injury Response Epidemiology/Surveillance Task Force.

MMWR Morb Mortal Wkly Rep. 2019 Dec 13;68(49):1142-1148. doi: 10.15585/mmwr.mm6849e1. No abstract available.

PMID:
31830008
2.

Update: Interim guidance for health care providers evaluating and caring for patients with suspected e-cigarette, or vaping, product use associated lung Injury - United States, October 2019.

Siegel DA, Jatlaoui TC, Koumans EH, Kiernan EA, Layer M, Cates JE, Kimball A, Weissman DN, Petersen EE, Reagan-Steiner S, Godfred-Cato S, Moulia D, Moritz E, Lehnert JD, Mitchko J, London J, Zaki SR, King BA, Jones CM, Patel A, Meaney Delman D, Koppaka R; Lung Injury Response Clinical Working Group; Lung Injury Response Epidemiology/Surveillance Group.

Am J Transplant. 2019 Dec;19(12):3420-3428. doi: 10.1111/ajt.15690. No abstract available.

PMID:
31778010
3.

Characteristics of Hospitalized and Nonhospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury - United States, November 2019.

Chatham-Stephens K, Roguski K, Jang Y, Cho P, Jatlaoui TC, Kabbani S, Glidden E, Ussery EN, Trivers KF, Evans ME, King BA, Rose DA, Jones CM, Baldwin G, Delaney LJ, Briss P, Ritchey MD; Lung Injury Response Epidemiology/Surveillance Task Force; Lung Injury Response Clinical Task Force.

MMWR Morb Mortal Wkly Rep. 2019 Nov 22;68(46):1076-1080. doi: 10.15585/mmwr.mm6846e1.

4.

Update: Interim Guidance for Health Care Providers for Managing Patients with Suspected E-cigarette, or Vaping, Product Use-Associated Lung Injury - United States, November 2019.

Jatlaoui TC, Wiltz JL, Kabbani S, Siegel DA, Koppaka R, Montandon M, Adkins SH, Weissman DN, Koumans EH, O'Hegarty M, O'Sullivan MC, Ritchey MD, Chatham-Stephens K, Kiernan EA, Layer M, Reagan-Steiner S, Legha JK, Shealy K, King BA, Jones CM, Baldwin GT, Rose DA, Delaney LJ, Briss P, Evans ME; Lung Injury Response Clinical Working Group.

MMWR Morb Mortal Wkly Rep. 2019 Nov 22;68(46):1081-1086. doi: 10.15585/mmwr.mm6846e2.

5.

Pulmonary Illness Related to E-Cigarette Use. Reply.

Layden JE, King BA, Meiman J.

N Engl J Med. 2019 Nov 20. pii: 10.1056/NEJMc1915111#sa3. doi: 10.1056/NEJMc1915111. [Epub ahead of print] No abstract available.

PMID:
31747505
6.

Risk Factors for E-Cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI) Among Adults Who Use E-Cigarette, or Vaping, Products - Illinois, July-October 2019.

Navon L, Jones CM, Ghinai I, King BA, Briss PA, Hacker KA, Layden JE.

MMWR Morb Mortal Wkly Rep. 2019 Nov 15;68(45):1034-1039. doi: 10.15585/mmwr.mm6845e1.

7.

Evaluation of Bronchoalveolar Lavage Fluid from Patients in an Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury - 10 States, August-October 2019.

Blount BC, Karwowski MP, Morel-Espinosa M, Rees J, Sosnoff C, Cowan E, Gardner M, Wang L, Valentin-Blasini L, Silva L, De Jesús VR, Kuklenyik Z, Watson C, Seyler T, Xia B, Chambers D, Briss P, King BA, Delaney L, Jones CM, Baldwin GT, Barr JR, Thomas J, Pirkle JL.

MMWR Morb Mortal Wkly Rep. 2019 Nov 15;68(45):1040-1041. doi: 10.15585/mmwr.mm6845e2.

8.

Tobacco and Marijuana Use Among US College and Noncollege Young Adults, 2002-2016.

Odani S, Soura BD, Tynan MA, Lavinghouze R, King BA, Agaku I.

Pediatrics. 2019 Dec;144(6). pii: e20191372. doi: 10.1542/peds.2019-1372. Epub 2019 Nov 11.

PMID:
31712275
9.

e-Cigarette Use Among Youth in the United States, 2019.

Cullen KA, Gentzke AS, Sawdey MD, Chang JT, Anic GM, Wang TW, Creamer MR, Jamal A, Ambrose BK, King BA.

JAMA. 2019 Nov 5. doi: 10.1001/jama.2019.18387. [Epub ahead of print]

PMID:
31688912
10.

E-Cigarette Use and Subsequent Cigarette Initiation and Sustained Use Among Youth, U.S., 2015-2017.

Odani S, Armour BS, King BA, Agaku IT.

J Adolesc Health. 2019 Nov 1. pii: S1054-139X(19)30432-X. doi: 10.1016/j.jadohealth.2019.08.021. [Epub ahead of print]

PMID:
31685373
11.

Update: Characteristics of Patients in a National Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injuries - United States, October 2019.

Moritz ED, Zapata LB, Lekiachvili A, Glidden E, Annor FB, Werner AK, Ussery EN, Hughes MM, Kimball A, DeSisto CL, Kenemer B, Shamout M, Garcia MC, Reagan-Steiner S, Petersen EE, Koumans EH, Ritchey MD, King BA, Jones CM, Briss PA, Delaney L, Patel A, Polen KD, Sives K, Meaney-Delman D, Chatham-Stephens K; Lung Injury Response Epidemiology/Surveillance Group; Lung Injury Response Epidemiology/Surveillance Task Force.

MMWR Morb Mortal Wkly Rep. 2019 Nov 1;68(43):985-989. doi: 10.15585/mmwr.mm6843e1.

12.

Adults' favorability toward prohibiting flavors in all tobacco products in the United States.

Agaku IT, Odani S, Armour BS, King BA.

Prev Med. 2019 Dec;129:105862. doi: 10.1016/j.ypmed.2019.105862. Epub 2019 Oct 23.

PMID:
31655175
13.

Update: Interim Guidance for Health Care Providers Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use Associated Lung Injury - United States, October 2019.

Siegel DA, Jatlaoui TC, Koumans EH, Kiernan EA, Layer M, Cates JE, Kimball A, Weissman DN, Petersen EE, Reagan-Steiner S, Godfred-Cato S, Moulia D, Moritz E, Lehnert JD, Mitchko J, London J, Zaki SR, King BA, Jones CM, Patel A, Delman DM, Koppaka R; Lung Injury Response Clinical Working Group; Lung Injury Response Epidemiology/Surveillance Group.

MMWR Morb Mortal Wkly Rep. 2019 Oct 18;68(41):919-927. doi: 10.15585/mmwr.mm6841e3.

14.

Evidence of the Impact of the Tips From Former Smokers Campaign: Results From the Behavioral Risk Factor Surveillance System.

Davis KC, Murphy-Hoefer R, Levine B, King BA, Hu S, Rodes R.

Prev Chronic Dis. 2019 Oct 10;16:E137. doi: 10.5888/pcd16.190110.

15.

Characteristics of a Multistate Outbreak of Lung Injury Associated with E-cigarette Use, or Vaping - United States, 2019.

Perrine CG, Pickens CM, Boehmer TK, King BA, Jones CM, DeSisto CL, Duca LM, Lekiachvili A, Kenemer B, Shamout M, Landen MG, Lynfield R, Ghinai I, Heinzerling A, Lewis N, Pray IW, Tanz LJ, Patel A, Briss PA; Lung Injury Response Epidemiology/Surveillance Group.

MMWR Morb Mortal Wkly Rep. 2019 Oct 4;68(39):860-864. doi: 10.15585/mmwr.mm6839e1. Erratum in: MMWR Morb Mortal Wkly Rep. 2019 Oct 11;68(40):900.

16.

Flavored Tobacco Product Use Among Middle and High School Students - United States, 2014-2018.

Cullen KA, Liu ST, Bernat JK, Slavit WI, Tynan MA, King BA, Neff LJ.

MMWR Morb Mortal Wkly Rep. 2019 Oct 4;68(39):839-844. doi: 10.15585/mmwr.mm6839a2.

17.

Iodine-125 Episcleral Plaque Brachytherapy for AJCC T4 Posterior Uveal Melanoma: Clinical Outcomes in 158 Patients.

King BA, Awh C, Gao BT, Wang J, Kocak M, Morales-Tirado VM, Ballo MT, Wilson MW.

Ocul Oncol Pathol. 2019 Aug;5(5):340-349. doi: 10.1159/000495249. Epub 2019 Jan 10.

PMID:
31559245
18.

Differences in price of flavoured and non-flavoured tobacco products sold in the USA, 2011-2016.

Agaku IT, Odani S, Armour B, Mahoney M, Garrett BE, Loomis BR, Rogers T, Gammon DG, King BA.

Tob Control. 2019 Sep 18. pii: tobaccocontrol-2019-055111. doi: 10.1136/tobaccocontrol-2019-055111. [Epub ahead of print]

PMID:
31537629
19.

Severe Pulmonary Disease Associated with Electronic-Cigarette-Product Use - Interim Guidance.

Schier JG, Meiman JG, Layden J, Mikosz CA, VanFrank B, King BA, Salvatore PP, Weissman DN, Thomas J, Melstrom PC, Baldwin GT, Parker EM, Courtney-Long EA, Krishnasamy VP, Pickens CM, Evans ME, Tsay SV, Powell KM, Kiernan EA, Marynak KL, Adjemian J, Holton K, Armour BS, England LJ, Briss PA, Houry D, Hacker KA, Reagan-Steiner S, Zaki S, Meaney-Delman D; CDC 2019 Lung Injury Response Group.

MMWR Morb Mortal Wkly Rep. 2019 Sep 13;68(36):787-790. doi: 10.15585/mmwr.mm6836e2. Erratum in: MMWR Morb Mortal Wkly Rep. 2019 Sep 27;68(38):830.

20.

Combination tofacitinib and oral minoxidil treatment for severe alopecia areata.

Wambier CG, Craiglow BG, King BA.

J Am Acad Dermatol. 2019 Sep 6. pii: S0190-9622(19)32688-X. doi: 10.1016/j.jaad.2019.08.080. [Epub ahead of print] No abstract available.

PMID:
31499158
21.

Pulmonary Illness Related to E-Cigarette Use in Illinois and Wisconsin - Preliminary Report.

Layden JE, Ghinai I, Pray I, Kimball A, Layer M, Tenforde M, Navon L, Hoots B, Salvatore PP, Elderbrook M, Haupt T, Kanne J, Patel MT, Saathoff-Huber L, King BA, Schier JG, Mikosz CA, Meiman J.

N Engl J Med. 2019 Sep 6. doi: 10.1056/NEJMoa1911614. [Epub ahead of print]

PMID:
31491072
22.

Reply to: "Comment on 'Rule of thumb: A simple tool to estimate 1% scalp surface area': Whose thumb is it anyway?"

Wambier CG, King BA.

J Am Acad Dermatol. 2019 Dec;81(6):e185. doi: 10.1016/j.jaad.2019.08.051. Epub 2019 Aug 27. No abstract available.

PMID:
31470070
23.

IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans.

Ortolan LS, Kim SR, Crotts S, Liu LY, Craiglow BG, Wambier C, Paschoal RS, King BA, Jabbari A.

J Allergy Clin Immunol. 2019 Dec;144(6):1731-1734.e1. doi: 10.1016/j.jaci.2019.08.014. Epub 2019 Aug 27. No abstract available.

PMID:
31470035
24.

Patterns of nicotine concentrations in electronic cigarettes sold in the United States, 2013-2018.

Romberg AR, Miller Lo EJ, Cuccia AF, Willett JG, Xiao H, Hair EC, Vallone DM, Marynak K, King BA.

Drug Alcohol Depend. 2019 Oct 1;203:1-7. doi: 10.1016/j.drugalcdep.2019.05.029. Epub 2019 Jul 19.

PMID:
31386973
25.

U.S. Adults' Attitudes Toward Lowering Nicotine Levels in Cigarettes.

Ali FRM, Al-Shawaf M, Wang TW, King BA.

Am J Prev Med. 2019 Sep;57(3):403-407. doi: 10.1016/j.amepre.2019.04.016. Epub 2019 Jul 11.

PMID:
31303387
26.

Socioeconomic Differences in Cigarette Smoking Among Sociodemographic Groups.

Garrett BE, Martell BN, Caraballo RS, King BA.

Prev Chronic Dis. 2019 Jun 13;16:E74. doi: 10.5888/pcd16.180553.

27.

Prevalence and correlates of secondhand smoke exposure in the home and in a vehicle among youth in the United States.

Agaku IT, Odani S, King BA, Armour BS.

Prev Med. 2019 Sep;126:105745. doi: 10.1016/j.ypmed.2019.06.003. Epub 2019 Jun 5.

PMID:
31175879
28.

Use and reasons for use of electronic vapour products shaped like USB flash drives among a national sample of adults.

Marynak KL, Ali FRM, Schauer GL, Tynan MA, King BA.

Tob Control. 2019 Nov;28(6):685-688. doi: 10.1136/tobaccocontrol-2019-054932. Epub 2019 Apr 25.

PMID:
31023856
29.

Exposure to Secondhand Smoke and Secondhand E-Cigarette Aerosol Among Middle and High School Students.

Gentzke AS, Wang TW, Marynak KL, Trivers KF, King BA.

Prev Chronic Dis. 2019 Apr 4;16:E42. doi: 10.5888/pcd16.180531.

30.

E-Cigarettes and Young People: Communicating an Emerging Public Health Risk.

Mitchko J, Lewis S, Marynak KL, Shannon C, Burnette D, King BA.

Am J Health Promot. 2019 Jul;33(6):955-957. doi: 10.1177/0890117119835519. Epub 2019 Mar 14.

PMID:
30871329
31.

Water Pipe (Hookah) Smoking and Cardiovascular Disease Risk: A Scientific Statement From the American Heart Association.

Bhatnagar A, Maziak W, Eissenberg T, Ward KD, Thurston G, King BA, Sutfin EL, Cobb CO, Griffiths M, Goldstein LB, Rezk-Hanna M.

Circulation. 2019 May 7;139(19):e917-e936. doi: 10.1161/CIR.0000000000000671.

PMID:
30845826
32.

State-Specific Cessation Behaviors Among Adult Cigarette Smokers - United States, 2014-2015.

Wang TW, Walton K, Jamal A, Babb SD, Schecter A, Prutzman YM, King BA.

Prev Chronic Dis. 2019 Mar 7;16:E26. doi: 10.5888/pcd16.180349.

33.

Use of Electronic Vapor Products Before, During, and After Pregnancy Among Women with a Recent Live Birth - Oklahoma and Texas, 2015.

Kapaya M, D'Angelo DV, Tong VT, England L, Ruffo N, Cox S, Warner L, Bombard J, Guthrie T, Lampkins A, King BA.

MMWR Morb Mortal Wkly Rep. 2019 Mar 1;68(8):189-194. doi: 10.15585/mmwr.mm6808a1.

34.

Workplace Smoke-Free Policies and Cessation Programs Among U.S. Working Adults.

Syamlal G, King BA, Mazurek JM.

Am J Prev Med. 2019 Apr;56(4):548-562. doi: 10.1016/j.amepre.2018.10.030. Epub 2019 Feb 14.

35.

Vital Signs: Tobacco Product Use Among Middle and High School Students - United States, 2011-2018.

Gentzke AS, Creamer M, Cullen KA, Ambrose BK, Willis G, Jamal A, King BA.

MMWR Morb Mortal Wkly Rep. 2019 Feb 15;68(6):157-164. doi: 10.15585/mmwr.mm6806e1.

36.

Trends in the use of cigarettes, cigars, and marijuana among students with and without asthma, 2003-2017.

Everett Jones S, King BA, Leroy Z.

J Asthma. 2019 Feb 7:1-7. doi: 10.1080/02770903.2019.1573254. [Epub ahead of print]

PMID:
30729834
37.

Rule of thumb: A simple tool to estimate 1% scalp surface area.

Wambier CG, King BA.

J Am Acad Dermatol. 2019 Aug;81(2):630-631. doi: 10.1016/j.jaad.2019.01.022. Epub 2019 Jan 23. No abstract available.

PMID:
30682394
38.

Targeted Treatment of TREX1 Chilblain Lupus and Other Interferonopathies-Taming T REX.

Damsky W, King BA.

JAMA Dermatol. 2019 Mar 1;155(3):283-284. doi: 10.1001/jamadermatol.2018.4836. No abstract available.

PMID:
30673073
39.

Curiosity About and Susceptibility Toward Hookah Smoking Among Middle and High School Students.

Gentzke AS, Wang B, Robinson JN, Phillips E, King BA.

Prev Chronic Dis. 2019 Jan 10;16:E04. doi: 10.5888/pcd16.180288.

40.

Response to tofacitinib therapy of eyebrows and eyelashes in alopecia areata.

Liu LY, King BA.

J Am Acad Dermatol. 2019 Jun;80(6):1778-1779. doi: 10.1016/j.jaad.2018.11.037. Epub 2018 Nov 28. No abstract available.

PMID:
30502414
41.

U.S. Adult Attitudes About Electronic Vapor Product Use in Indoor Public Places.

Wang TW, Marynak KM, Gentzke AS, King BA.

Am J Prev Med. 2019 Jan;56(1):134-140. doi: 10.1016/j.amepre.2018.08.022. Epub 2018 Nov 19.

42.

Notes from the Field: Use of Electronic Cigarettes and Any Tobacco Product Among Middle and High School Students - United States, 2011-2018.

Cullen KA, Ambrose BK, Gentzke AS, Apelberg BJ, Jamal A, King BA.

MMWR Morb Mortal Wkly Rep. 2018 Nov 16;67(45):1276-1277. doi: 10.15585/mmwr.mm6745a5. No abstract available.

43.

Tobacco Product Use Among Adults - United States, 2017.

Wang TW, Asman K, Gentzke AS, Cullen KA, Holder-Hayes E, Reyes-Guzman C, Jamal A, Neff L, King BA.

MMWR Morb Mortal Wkly Rep. 2018 Nov 9;67(44):1225-1232. doi: 10.15585/mmwr.mm6744a2.

44.

Cicatrizing Blepharoconjunctivitis Occurring During Dupilumab Treatment and a Proposed Algorithm for Its Management.

Levine RM, Tattersall IW, Gaudio PA, King BA.

JAMA Dermatol. 2018 Dec 1;154(12):1485-1486. doi: 10.1001/jamadermatol.2018.3427. No abstract available.

PMID:
30347029
45.

Electronic Cigarette Sales in the United States, 2013-2017.

King BA, Gammon DG, Marynak KL, Rogers T.

JAMA. 2018 Oct 2;320(13):1379-1380. doi: 10.1001/jama.2018.10488. No abstract available.

46.

Rethinking the classification of alopecia areata.

Wambier CG, King BA.

J Am Acad Dermatol. 2019 Feb;80(2):e45. doi: 10.1016/j.jaad.2018.08.059. Epub 2018 Sep 20. No abstract available.

PMID:
30244065
47.

Tobacco product use among workers in the construction industry, United States, 2014-2016.

Syamlal G, King BA, Mazurek JM.

Am J Ind Med. 2018 Nov;61(11):939-951. doi: 10.1002/ajim.22907. Epub 2018 Sep 19.

48.

Ruxolitinib for the treatment of severe alopecia areata.

Liu LY, King BA.

J Am Acad Dermatol. 2019 Feb;80(2):566-568. doi: 10.1016/j.jaad.2018.08.040. Epub 2018 Sep 6. No abstract available.

PMID:
30195572
49.

Tofacitinib for the treatment of alopecia areata in preadolescent children.

Craiglow BG, King BA.

J Am Acad Dermatol. 2019 Feb;80(2):568-570. doi: 10.1016/j.jaad.2018.08.041. Epub 2018 Sep 6. No abstract available.

PMID:
30195571
50.

Uveal metastases in the mid-southeastern United States: a single-institution experience.

King BA, Rosenberger EU, Morales-Tirado VM, Wilson MW.

Clin Ophthalmol. 2018 Aug 17;12:1459-1463. doi: 10.2147/OPTH.S172464. eCollection 2018.

Supplemental Content

Support Center